ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PDT Prelude Tst.

80.00
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Prelude Tst. LSE:PDT London Ordinary Share GB0006992480 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 80.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Prelude Trust Share Discussion Threads

Showing 7701 to 7725 of 8575 messages
Chat Pages: Latest  319  318  317  316  315  314  313  312  311  310  309  308  Older
DateSubjectAuthorDiscuss
15/3/2007
20:38
More Displaylink news. Another day at CEBIT, another link up. Sunix, based in Taiwan, plans to market the VGA2625 "aggressively in Europe and Latin America, where it has a strong brand name and distribution channel." Its customers include Fujitsu-Siemens, IBM and Quantum.

DISPLAYLINK AND SUNIX BRING NETWORK DISPLAY SOLUTION TO EUROPE AT CeBIT

Sunix Chooses Innovative USB Network Display Technology from DisplayLink For
Family of USB-to-VGA / DVI Adapters

HANNOVER, Germany – CeBIT - March 15, 2007 – DisplayLink Inc. (formerly Newnham Technology) today announced that Sunix has chosen its network display technology for the new Sunix VGA2625 family of USB-to-VGA / DVI adapters. Sunix, based in Taiwan, plans to market the VGA2625 aggressively in Europe and Latin America, where it has a strong brand name and distribution channel.

The VGA2625 family provides a cost-effective and easy-to-use solution for adding extra monitors to a computer using USB 2.0 without requiring additional graphics cards. Sunix is introducing the product family today at the CeBIT 2007 conference being held March 15-21 in Hannover, Germany.

"Consumers look to Sunix for a full line of USB products and adding display connectivity solutions with the VGA2625 family offers us an opportunity to expand our solutions to meet a new customer need," said Arthur Lin, CEO, Sunix. "DisplayLink's network display technology gives us the performance and simplicity we need to deliver the experience and value our customers expect."

"Adding additional monitors to a computer is one of the easiest ways for consumers to have more fun and be more productive with their computers," said Dennis Crespo, executive vice president of marketing and business development for DisplayLink. "The Sunix solution gives consumers the ability to add any monitor type and size – from a high-resolution flat screen to a digital picture frame – simply and cost effectively."

The VGA2625 family utilizes DisplayLink's Virtual Graphics Adapter software running on a Windows host computer, which compresses video data for transport over USB 2.0 and works with the operating system to remember all display configuration data for instant monitor connections.

Built into the adapters are DisplayLink's DL-120 and DL-160 chips, which convert the compressed video information into pixels for the display. The DL-120 is used in the VGA2615 USB-to-VGA adapter that supports 24-bit color and screen resolutions up to 1400 x 1050.

The DL-160 is used in the VGA2625P, a USB-to-DVI adapter and the VGA2615P a USB-to-VGA adapter. Both adapters support 24-bit color and high-resolution displays up to 1680 x 1050.

The DisplayLink solution allows all of the VGA2625 adapters to offer DVD-quality video playback and instant interactivity for mouse and keyboard input.

DisplayLink's network display technology breaks the inherent 1:1 PC-to-monitor connectivity constraints of VGA/DVI, providing the ability to network multiple monitors, laptop docks, digital picture frames and other devices to a computer. The technology also supports monitor connections over wireless USB, Wi-Fi, Ethernet and other networks.

About Sunix
Founded in 1986, SUNIX specializes in the research and development of technology for I/O controller cards and markets its controller cards in the European market under the "Sunix" brand name. The technology and quality built into each and every Sunix I/O controller card has earned the company's products the nickname "Golden Card." Its customers include Fujitsu-Siemens, IBM and Quantum. Sunix is based in Taipei, Taiwan. More information can be found at www.sunix.com.tw.

orange1
15/3/2007
12:25
And here is a pretty picture to illustrate the news:
orange1
15/3/2007
12:23
Whilst we wait for the beach bum to return, here is news of a link-up between DisplayLink and Samsung:

DISPLAYLINK TECHNOLOGY CHOSEN FOR WORLD'S FIRST NETWORK DISPLAY
OFFERING GRAPHICS AND VIDEO OVER USB

New USB-Connected Monitor can be Daisy-Chain Connected for Adding More Than One Display to a PC

PALO ALTO, CALIF. - March 14, 2007 – DisplayLink Inc. today announced that Samsung, a world leader in computer displays, has chosen DisplayLink's USB graphics networking technology for its SyncMaster 940UX, the world's first display that delivers crisp, high-quality graphics across a USB 2.0 link

The SyncMaster 940UX is a 19-inch display powered by the DisplayLink DL-120 chip, a network display chip that powers high-quality, fully interactive SXGA (1280x1024), 32-bit true-color graphics and real-time video playback across USB. With a four-port USB hub built into the display, up to five additional SyncMaster 940UX monitors can be daisy chain connected to a PC while consuming only one USB 2.0 port on the computer.

The SyncMaster 940UX meets the demands of knowledge workers and consumers for more screen area for their applications and data without increased complexity. DisplayLink's graphics software matches the simplicity of USB by leveraging Windows display configuration tools and remembering monitor configurations, providing an "instant install" capability for connecting or reconnecting multiple displays to a PC or laptop.

"Consumers are clamoring for more screen space, but are deterred by the cost and complexity of typical solutions. USB network displays open up a whole range of solutions that allow mainstream users to easily add additional monitors," said Hamid Farzaneh, Chief Executive Officer for DisplayLink. "Samsung is a pioneer in this market and has the brand name and consumer trust that make it a great partner to go to market with."

DisplayLink's network display chip family includes the DL-160 and DL-120 high-performance graphics networking chips. These are designed for monitor manufacturers, PC OEMs and PC accessory companies who want to develop network display products including USB-connected monitors, video-capable USB laptop docking stations, Skype video phones, picture frames and other devices.

The complete DisplayLink solution is comprised of Virtual Graphics Card (VGC) software that runs on a Windows host PC, and a Hardware Rendering Engine (HRE) inside the DL-120 or DL-160 chip at the display end. The VGC software processes a stream of display information using the company's proprietary adaptive graphics protocol and transmits it over a USB 2.0, wireless USB, or Wi-Fi link to the DL-120 or DL-160 chip that reconstructs the image on the display.

orange1
14/3/2007
16:55
Bitochon

You are right. Riv is currently on the beach.

orange1
14/3/2007
16:08
Board's been quiet of late. Guess rivaldo is away on holiday! Hope he's enjoying himself (at least the sea's blue and not like my screen, red!). Sorry to be o/t but I would welcome his views on CS's current HOLD stance on RCG. Good luck to all and let's hope Uncle Sam doesn't drag us down too far!
bitochon
07/3/2007
22:32
No probs. £14k of buys on PLUS today presumably the reason for the tick up.

Amazing really. 40% of the m/cap is in cash, plus:

-ZBD
-Oxford Immunotec
-DisplayLink
-M-Spatial
-Phyworks
-Polatis
-Siconnect

all looking great, plus Kiadis, Sciona and De Novo all seemingly expanding and reporting milestones and deals.

Still a long way for the share price to go to the 150p or so NAV, let alone any further.

rivaldo
07/3/2007
17:20
Thanks Riv.
2prsimo
07/3/2007
16:30
Thank you for the posts riv,

Am sure all this good news will be noticed.

hvs
07/3/2007
16:08
This sounds like significant and positive news for Oxford Immunotec to my untrained eyes:



"Study results support use of T-SPOT.TB to monitor latent TB infection
Oxford, UK; 5th March 2007 – Oxford Immunotec Ltd, the T cell measurement company, today announced the publication of a recent study demonstrating the potential use of T-SPOT.TB to monitor the effect of treatment for latent tuberculosis infection.

In the study run at the Singapore TB control unit and reported in the American Journal of Critical Care Medicine, Chee et al investigated the potential use of T-SPOT.TB to monitor the efficacy of treatment for latent TB infection. In low TB burden countries, widespread screening for latent TB is a key tool in
preventing the spread of TB. However, there is currently no way to assess the efficacy of latent TB treatment. Development of an effective tool to monitor the success of treatment would therefore represent a major step forwards and would be a vital addition to the existing tools for TB control.

In the study, 226 patients with prior exposure to TB and who had tested positive using T-SPOT.TB were treated for latent TB infection. The vast majority (96%) of patients received a 6 month course of Isoniazid with the remaining 4% receiving alternate treatments including a combination of Isoniazid with Rifampicin. At the end of the treatment period the patients were repeat tested with T-SPOT.TB.

The results demonstrated that there was a statistically significant change, as reflected by reversion from a positive to a negative result and by absolute spot count, for one of the two TB specific antigens used in the test, CFP-10 whereas the response to the other antigen, ESAT-6 was unchanged with
treatment. The significant reduction in response to CFP-10 was consistent with the hypothesis that there is clearing of the CFP-10 antigen as the mycobacterial load declines with treatment and was repeated across both the Isoniazid group and the other treatment regimes. The lack of change in
response to ESAT-6 was also examined and a possible explanation supported by evidence published in other papers.

Commenting on the results, Dr Peter Wrighton-Smith, Chief Executive Officer of Oxford Immunotec said, "This study has demonstrated for the first time the potential to use T-SPOT.TB as an effective tool to monitor the treatment of latent TB infection. These preliminary findings, if supported by future
studies, could lead to the development of an efficient and effective way to monitor the progression of treatment and the clearance of disease, providing a key tool in the control of latent TB infection. In addition, the T-SPOT.TB test may have a role to play in the testing of new anti-TB therapies.""

rivaldo
07/3/2007
12:44
Sciona are covered here:


"Breakthrough technology
It's all about me! Nutrition gets personal

By Jess Halliday
07/03/2007 - Imagine if I could purchase a product that is exactly suited to disease prevention for my own, individual genetic make-up. Sounds like something from science fiction, but with the twin areas of nutrigenomics and personalised nutrition developing apace, the mass availability of tailored foods and supplements may not be too far in the future.

Nutrigenomics is the science of how food and ingested nutrients affect genes - particularly those related to disease prevention.

Granted, it's a science still very much in its infancy - the term nutrigenomics was only coined in 1999. The umbrella area of genomics is vastly complex, and the task of unravelling exactly which genes are responsible for exactly which events is no mean undertaking.

But after long-haul R&D and repeated rounds of funding, the pioneers in isolating nutrients that have actions on human genes are communicating their progress - and are readying the fruits of their labours for market.

For instance, after ten years of research and development, the first two ingredients developed by WellGen using nutrigenomics principles are approaching the end of its pipeline. Last autumn the US company said it was in the process of negotiating partnerships with food companies.

Its black tea-derived ingredient was the subject of human trials into its role in turning off genes involves in inflammation; and the orange peel ingredient of non-human clinical trials on its potential to support weight control.

In New Zealand, a collaborative project is also underway in New Zealand to examine the link between food and disease at a molecular genetic level; crown research organisation HortResearch has reported positive preliminary results on how apple extracts impact genes associated with Crohn's disease.

For people with funding to dish, nutrigenomics is an area that they seem willing to hedge their bets.

Last August the US Department of Agriculture earmarked $25m for a new $25m laboratory and office building in Davis, California briefed to fight obesity and chronic disease through nutrition research. Nutrigenomics is one of the core foci of the research team.

Next month a major symposium on nutritional biotechnology will take place at the University of North Carolina at Charlotte, to celebrate the development of the campus as a center for nutrition-related biotechnology research.

But when it comes to actually applying nutrigenomics-based ingredients to real people with real, varied genetic make-ups - that's when the secondary area of new technology comes into play: personalised nutrition testing.

Amongst the pack leaders are four US companies - Sciona, Genelex, Market America, and Suracell - which have each developed tests aimed at the consumer market.

The idea of personalised nutrition testing is not without its controversy. A recent article in the magazine New Scientist argued that companies offering tests are piggy-backing on a science that is not well established enough to justify the hefty prices they charge.

(Prices are said to range from $100 to $1000. Sciona's MyCellf programme, which analyses 19 genes that may play an important role in how a person's body manages bone health, heart health, antioxidant and detoxification function, insulin sensitivity and inflammation, sells online for $260.)

"Discussing family history with a physician and taking a few blood tests [in order to]... give you a similar or more accurate snapshot of your current health," wrote New Scientist author Bijal Trivedi.

Trivedi's conclusions were fuelled in part by a report from the US Government Accountability Office, which said that some personalised nutrition companies "misled consumers by making predictions that are medically unproven and so ambiguous that they do not provide meaningful information."

Not all of the testing companies have made the leap across the gulf that still exists between test results and selling products they say address the individual's needs. Suracell does offer "a personalised protocol of nutraceutical formulations" based on the results - as well as a daily core nutrition formula.

Sciona, on the other hand (in which the venturing arm of Dutch chemicals group DSM is a mahor shareholder) argues that it does not diagnose or predict disease in its consumer reports. It simply says that, by understand the influence of genes on health, it can help consumers make health-promoting diet and lifestyle choices.

The main proponents of personalised nutrition admit that nutrigenomics is a technology that still has far to go before it can have a major bearing on nutrition and the food industry at large. But roads into greater understanding are being made - and in terms of marketing, the path has already been somewhat prepared.

In a sense, personalised nutrition is an extension of supplement marketers' strategy of growing their market by tailoring product design to the specific needs of a particular section of the population - pregnant women, sporty types, the over-50s, for instance.

It has proved a successful model, as the marketers have managed to prod growth out of multivitamins which, as a one-size-fits-all category, was generally accepted to have reached maturity.

The ability to tailor products to fit a consumer's needs even more snugly is the next logical step. How much more snug can it get than fitting one's own genes like a glove?"

rivaldo
07/3/2007
10:42
Yep, must be buying demand out there as the only declared trades are 10k of sells, so the tick up is very good news.

Has anyone (tiltonboy, darren) seen anything from Winterfloods yet in the way of broker/buy notes or anything else? Or perhaps they'll wait till the 31/3 valuation is out?

rivaldo
07/3/2007
09:59
Good morning rivaldo,

Looks like someone is looking for stock. Small upticks could be a wooosh soon.

hvs
06/3/2007
15:22
I like the opening and the last paragraphs here - this is a breakthrough technology (good to see another tick up as well):



"Tue Mar 6, 2007
British firm helping shape the future of computer displays

This one sneaked in under the radar last week, but a medium-sized company from Cambridge, England, called DisplayLink has landed a significant contract with Toshiba that is almost certain to change the way we look at our computer monitors.

The contract sees DisplayLink's technology powering Toshiba's latest Dynadock range of laptop PC docks to enable them to deliver high-resolution images to full-size monitors via a USB 2.0 connection.

The £129.00 Dynadock PA3542E-1PRP that's available now in the UK plugs into a single USB 2.0 port on a laptop. It can drive a monitor up to 1680 x 1050 pixels while simultaneously powering a sound system and standard USB peripherals and while powering phones, PDAs and the like.

The advantage of the USB method is initially in reducing cable clutter by cutting out the standard VGA lead monitors have always used, but the next generation of DisplayLink technology is the one to look out for, as it will use wireless USB to drive displays with no cables at all."

rivaldo
06/3/2007
08:33
And Siconnect news:


"March 06, 2007 02:00 AM Eastern Time
ARC Announces New Licensing Agreements With Leading European Semiconductor Companies and Design Teams
ARC's Configurable Subsystems and Processors Driving High-Growth Applications Including Multimedia, GPS, and Networking

ELSTREE, England--(BUSINESS WIRE)--ARC International (LSE:ARK), the world leader in configurable subsystems and CPU/DSP processors, today announced new licensing agreements with leading European semiconductor companies and system-on-chip (SoC) design teams. All have adopted ARC's patented configurable Media Subsystems or processors for a variety of media, global positioning system (GPS), and home connectivity-centric chip designs."

"SiConnect, Limited

SiConnect, a leading suppler of in-home power line communications (PLC), has taken a license for a configurable ARC product to develop their next-generation of products. SiConnect's innovative POEM technology enables existing domestic electrical wiring to be used to transport audio, video, voice, and data throughout the home. Working in partnership with blue chip telecommunication operators, cable companies and consumer electronics manufacturers, SiConnect is creating new benchmarks for PLC technology that achieve all-capacity, reliability, ease-of-use, and cost-point requirements."

rivaldo
06/3/2007
07:31
No probs Spin. ZBD news - they've been shortlisted for Red Herring's 200 European companies for 2007, which is already good but extremely prestigious if they get further shortlisted as the list gets cut down:
rivaldo
05/3/2007
18:32
Have topped up again - risk reward ratio looks compelling. Very reassured at share price resilience.
Ta riv for continual portfolio updates.

Maybe the PR woman at PDT is on extended leave with nowt to do ;.)

spin doctor
05/3/2007
16:17
Came across this which hasn't been posted - an interesting techie chat re DisplayLink. I liked this extract:



"I wrote a couple of days back on the profound effect UWB display links could eventually have on the digital home, when potentially any device could use any monitor. This in turn could increase the popularity of small ultra-mobiles because they could always use a big screen when required."

rivaldo
05/3/2007
11:47
yes Riv - the only blue in a sea of red for me
2prsimo
05/3/2007
11:04
Nice to see a spot of blue amongst the carnage!
rivaldo
04/3/2007
18:49
I should say that recently I've tried to get hold of Jayne (PR) at PDT and have unusually been completely unsuccessful as she's been elsewhere/busy. I also note that the "Portfolio News" section of the web site hasn't been updated for some time, which is also unusual.

Dare I suggest that maybe there are events happening at PDT which are taking up the staff's time?

Meanwhile, Siconnect are showing this week at the IPTV World Forum in London:



"SiConnect demonstrates UDP multicast video streaming over powerline
March 2007
IPTV World Forum 07, Stand 43

In-home communications technology company SiConnect is to make its first public demonstration of UDP multicast video streaming at the IPTV World Forum. Based on its recently announced PLT050 powerline communication (PLC) transceiver chip, the demonstration will show the ease with which IPTV data can be distributed throughout the home via the domestic electrical wiring circuit.

"Achieving one-to-many broadcasting of IPTV data over powerline represents a significant step forward in the development of the digitally connected home," said Robert Stead, VP Marketing SiConnect. "Quality of service (QoS), whole home coverage and immunity to noise are prerequisites for such an application and SiConnect's POEMâ technology clearly proves its advantages in this demonstration."

Unlike its rivals, POEM technology employs a Synchronous Multiple Access / Contention Resolution (SMA/CR) protocol and a 16 service level QoS management technique to guarantee fair and prioritised distribution of competing multimedia data streams on the powerline network.

It ensures whole home coverage by using a peer-to-peer meshed network topology which enables each node to act as an intelligent repeater capable of creating 'ad hoc' networks. Since networks self-configure, user installation is 'plug and play' while POEM's in-built security assures privacy.

Global EMC compliance was another key design criteria in the development of SiConnect's technology. The PLT050 enable designers to produce products that comply with FCC Part 15, CISPR 22 and its European derivative EN55022 – a mandatory requirement for the marketing of consumer electronic in Europe."

rivaldo
04/3/2007
18:19
the market is not rational enough to guarantee 2007 hvs. value will out some time........
timtom2
04/3/2007
16:29
It cant get any better.

2007 is PDT yearfor very significant OUT PERFORMANCE.

hvs
02/3/2007
15:17
Phyworks news:



"Phyworks and Molex demonstrate robust transmission of 10.3125G over 1m copper backplane. (27th February 2007)
Date 27/02/2007
Phyworks (Bristol, UK) and Molex, Lisle, Illinois, USA (NASDAQ: MOLX and MOLXA)) today announced that they have demonstrated robust data transmission at 10.3 Gbps over 1 m of copper traces across a backplane. This makes it the first technological partnership to carry out a demonstration relevant to some of the targets of the emerging IEEE 802.3ap 10G Ethernet standard.

The demonstration took place at the DesignCon show in Santa Clara during the last week of January 2007, and featured the Molex I-Trac broadside-coupled backplane connector system and Phyworks equalizer-enabled Backplane Interface Device (BID). The companies showed robust 10 Gbps data transmission in the presence of crosstalk aggressors; a feat that enables system suppliers to communicate at high data-rates between devices and cards using minimal components.

Phyworks' contribution to the demonstration, the PHY1066, a high performance 10 Gbps BID offers exceptional channel equalization, compensating for the intersymbol interference that occurs when data is transmitted at high speed over a copper backplane. This is achieved using novel adaptation algorithms together with low distortion signal path circuit technology and a high performance CDR.

The PHY1066 is available immediately for evaluation as the first of a roadmap of equalizing BIDs based on Phyworks' patented CMOS equalizer technology, offering low power consumption and high density.

The Molex I-Trac connector system offers superior impedance control, lower cross-talk and higher overall bandwidth. With its open pin-field design, the system gives customers the flexibility to assign high-speed differential pairs, low-speed signals, power and ground contacts anywhere within the pin-field.

Speaking of the achievement, Brad Weaterton, Phyworks' Director of Marketing said "The combination of the Molex high speed interconnect technology with Phyworks' equalizer expertise, opens new opportunities for upgrading and reuse of existing backplanes. This will allow higher data-rate and throughput than envisaged previously. As part of Phyworks' long term strategy, we can engage key global partners, using our core CMOS equalization technology, applied to multiple markets."

Gourgen Oganessyan, senior signal integrity engineer, Molex, also commented on the demonstration saying" We are extremely excited to be able to demonstrate real-world 10 Gbps performance of our backplane interconnect technology enabled by the Phyworks' Backplane Interface Device. As the industry broadens its adoption of multi-gigabit systems, a demonstration of error-free data transmission at 10.3 Gbps over a 1 meter FR408 I-Trac backplane channel provides an important assurance of practicality and robustness of such systems.""

rivaldo
01/3/2007
15:18
You're right, it was the day before - apologies! At least I got your trades right anyway....
rivaldo
01/3/2007
12:42
riv,

I can't see the 20K trades on PLUS yesterday!!!

tiltonboy

tiltonboy
Chat Pages: Latest  319  318  317  316  315  314  313  312  311  310  309  308  Older